<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-MLI-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Mali (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Mali: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Mali</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ML" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="ML" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Bamako</narrative>
   </name>
   <administrative code="ML" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>12.65 -8</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1508606</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2252838</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1932509</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">490725</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="MLIPEF-TCA-AEDES2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">273897</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-BAGE2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">90210</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-BAGE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">40320</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-DALBERG2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">116428</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">640019</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">339137</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-AEDES2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">197819</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">91558</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-DALBERG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">167419</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">47420</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">48714</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1068012</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">631895</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-AEDES2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">363469</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">37481</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-DALBERG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">517692</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">79033</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">85545</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">479872</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">369418</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-AEDES2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">217154</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">12494</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-DALBERG2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">24348</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">159957</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MLIPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">76773</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000997">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">43031</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001160">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">55038</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001300">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-50417</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">207213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-207213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000501">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-21"></transaction-date>
   <value currency="USD" value-date="2020-02-21">19032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000889">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">78393</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001041">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-23"></transaction-date>
   <value currency="USD" value-date="2020-03-23">19167</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001174">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-27"></transaction-date>
   <value currency="USD" value-date="2020-03-27">12244</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001637">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-23"></transaction-date>
   <value currency="USD" value-date="2020-04-23">78393</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002669">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-02"></transaction-date>
   <value currency="USD" value-date="2020-07-02">18337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-19032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">19032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005343">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">17797</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005369">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">81351</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005443">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">60025</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005374">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-3444</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005374">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">3444</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000757">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-24"></transaction-date>
   <value currency="USD" value-date="2021-02-24">8689</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001225">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">11556</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001225">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">6285</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002017">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-05"></transaction-date>
   <value currency="USD" value-date="2021-05-05">2012</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003560">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-30"></transaction-date>
   <value currency="USD" value-date="2021-07-30">33000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003872">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-17"></transaction-date>
   <value currency="USD" value-date="2021-08-17">81351</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004351">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-08"></transaction-date>
   <value currency="USD" value-date="2021-09-08">24599</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AEDES (l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">l&apos;Agence Europ&#xE9;enne pour le D&#xE9;veloppement et la Sant&#xE9;</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001222">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">47303</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BAGE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001351">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-15245</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BAGE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000319">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-21"></transaction-date>
   <value currency="USD" value-date="2019-11-21">45256</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BAGE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000847">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">40320</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">91558</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">37481</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000998">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">83744</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001161">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-2509</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001301">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-124750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003827">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">70348</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001316">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">19247</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001154">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">70348</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005358">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">11644</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005068">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">70347</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-22413</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-38783</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">22413</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">38783</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">15090</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001371">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">10620</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001370">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">55256</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002365">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-27"></transaction-date>
   <value currency="USD" value-date="2021-05-27">57347</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003095">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-07"></transaction-date>
   <value currency="USD" value-date="2021-07-07">86021</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003565">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-30"></transaction-date>
   <value currency="USD" value-date="2021-07-30">13867</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006948">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">80820</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007122">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-09"></transaction-date>
   <value currency="USD" value-date="2021-12-09">86021</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002045">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">30499</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006422">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">26858</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003107">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">9937</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">804</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-19545</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">19545</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">11081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">4913</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">33750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000848">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">640019</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">640008</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">428004</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">479872</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000849">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">339137</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">283075</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">348820</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">230318</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">139100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mali-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mali 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mali-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mali 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mali-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mali 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mali-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Mali 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-mali-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mali 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mali-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mali 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mali-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mali 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-mali-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Mali 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-MLI" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">X of un(der)immunized children are located through community relays and door to door approaches</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;identification des les strategies et interventions visant l&apos;amelioration de l&apos;utilisation des services de vaccinstion par les communautes ddes districts prioritaires des regions de Kayes, Segou , Mopti, Sikasso,">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Apres l&apos;identification et la priorisation des obstacles aux prestation de vaccination, des interventions pro-equit&#xE9; ont &#xE9;t&#xE9; propos&#xE9;es, valid&#xE9;es et mises en oeuvre. Il s&apos;agit de: 
1. la r&#xE9;organisation des services de vaccination pour rendre disponible la prestation de vaccination tous les jours ouvrables, y compris les WE et la vaccination dans les Communaut&#xE9;s difficiles d&apos;acc&#xE8;s comme les marches, sur les collines 
2. La mise en ?uvre des engagements pris dans le cadre des cadres de redevabilit&#xE9; par les &#xE9;quipes CSCom pour rendre permanente la prestation de vaccination les jours ouvrables et de rendre gratuite la carte de vaccination pour les mamans/gardiennes d&apos;enfants indigentes, 
3. L&apos;engagement de plus en plus affirme des ASACO &#xE0; soutenir les activit&#xE9;s de vaccination (cr&#xE9;dit de t&#xE9;l&#xE9;phone pour appeler les parents des enfants absents &#xE0; leur rendez-vous, la motivation des DTC et charge PEV CSCom pour le suivi des activit&#xE9;s des Femmes Leaders. 
4. Le suivi des cadres de redevabilit&#xE9; et l&apos;implication des Directeurs Techniques de Centre (DTC) et des ASACO pur am&#xE9;liorer l?accueil. 
5.Les Femmes Leaders soutiennent les activit&#xE9;s dans les Communaut&#xE9;s &#xE0; travers les causeries &#xE9;ducatives dans les groupements de femmes, les visites &#xE0; domicile et la recherche active des enfants non ou incompl&#xE8;tement vaccines.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du suivi des cadres de redevabilite et particulierement les plateformes urbaines de soutien a la vaccination dans les 06 Communes du Distict de Bamako ainsi aue l&apos;utilisation des echeanciers pour la reduction du notaux d&apos;abandon.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Compte tenu des rumeurs du au COVID et pour r&#xE9;duire les cas de refus dans les AS avec beaucoup d?enfants non vaccin&#xE9;s, le dialogue communautaire a &#xE9;t&#xE9; identifi&#xE9; comme &#xE9;tant un moyen pour y rem&#xE9;dier et cela a mis ensemble les parties prenantes dans l?identification des solutions. Ce dialogue, dans la r&#xE9;gion de Kayes a connu la participation de 412 leaders communautaires dont 136 femmes au niveau du district de Oussoubidiadjan (aires de sante de Sibindi, Bendougou, Diakon, Madihawaya, Oussoubidiagna et Touba) du district de Bafoulabe(Aire de sante de Oualia N&#xE9;guetabali Horokoto Sitakoto Marena Manantali Bafoulab&#xE9;) et a Yelimane. Il en est de m&#xEA;me de certaines AS de Mopti. Aussi ici, a Mopti, le renforcement des capacit&#xE9;s des relais des sites PDIs pour le suivi des enfants de 0 &#xE0; 23 mois a &#xE9;t&#xE9; aussi r&#xE9;alis&#xE9;. La grande contrainte &#xE0; l?am&#xE9;lioration des performances dans la r&#xE9;gion de Mopti est l?ins&#xE9;curit&#xE9; qui a gagn&#xE9; tous les 8 districts. Le taux d?abandon reste toujours dans les m&#xEA;mes proportions en 2021 qui est de 15% contre 17 % en 2020 
Les districts prioritaires au niveau de Sikasso ont regorg&#xE9; en 2020 un nombre important d&apos;enfants non vaccin&#xE9; en penta3 : Bougouni (539), Koutiala (1203), Yorosso (439). L?utilisation des fiches &#xE9;ch&#xE9;anciers dans les deux districts de Sikasso a permis la r&#xE9;duction des taux d&apos;abandon dans ces deux districts</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to overcome vaccine demand-related barriers in high risk communities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;identification des les strategies et interventions visant l&apos;amelioration de l&apos;utilisation des services de vaccinstion par les communautes ddes districts prioritaires des regions de Kayes, Segou , Mopti, Sikasso,">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Dans les r&#xE9;gions de Kayes, Sikasso, Mopti et S&#xE9;gou, l?am&#xE9;lioration de la demande est pass&#xE9;e par la mise en place des cadres de redevabilit&#xE9; et le suivi des engagements de contenus de ces cadres a permis par exemple dans le district de Kolondieba aux autorit&#xE9;s de la commune de Kebila de financer le d&#xE9;nombrement des enfants z&#xE9;ro-dose. L?organisation des dialogues communautaires a permis par exemple dans Kayes de toucher 1205 personnes dont 255 femmes. On a note ainsi une r&#xE9;duction du taux d&apos;abandon de 7,4% de janvier &#xE0; septembre 2020 &#xE0; 5,6% en 2021 pour la m&#xEA;me p&#xE9;riode le nombre de z&#xE9;ro dose est pass&#xE9; de 2519 enfants de janvier &#xE0; septembre 2020 &#xE0; 1405 enfants pour la m&#xEA;me p&#xE9;riode en 2021 pour la r&#xE9;gion (cumul district) selon le DHIS2. A Sikasso, les agents PEV ont eu aussi leur comp&#xE9;tence renforc&#xE9;e en utilisation des &#xE9;ch&#xE9;anciers. Ceci a permis de r&#xE9;duire le taux d?abandon penta 1-penta 3 d?au moins 2 points dans chaque district. La r&#xE9;duction a S&#xE9;gou n?a pas &#xE9;t&#xE9; tr&#xE8;s significative parce que ce taux d?abandon passe de 15.66% en 2020 a 14,3% en 2021 pour la m&#xEA;me p&#xE9;riode. cependant, toutes ces regions disposent des plans regionaux de communication en faveur du PEV de routine, de la Surveillance et des AVS qui a fait une analyse situationnelle regionale. Il reste l&apos;elaboration des plans de communication au niveau des districts</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique a l&apos;&#xE9;laboration du plan strat&#xE9;gique national de communication et de plans int&#xE9;gr&#xE9;s de communication et appuyer leur mise en place dans les DS prioritaires 
Apporter un appui technique pour le fonctionnement et le suivi des cadres e redevabilite dans les districts prioritaires
Actualiser/&#xE9;laborer des messages et supports de communication pour le PEV de routine
Documenter les bonnes pratiques sur l?engagement communautaire pour le PEV : Vid&#xE9;os/ articles/photographie de qualit&#xE9; ;">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Un atelier national de formation sur la planification strat&#xE9;gique en communication sur le PEV de routine, les AVS et la surveillance a base communautaire a &#xE9;t&#xE9; organis&#xE9; avec les acteurs du niveau national et des 10 r&#xE9;gions en plus du district de Bamako. A l?issue de cet atelier chaque r&#xE9;gion a &#xE9;labor&#xE9; sur la base d?un canevas clair un plan r&#xE9;gional int&#xE9;gr&#xE9; de communication. Les acteurs du niveau r&#xE9;gional &#xE9;taient compos&#xE9; des repr&#xE9;sentants du d&#xE9;veloppement social, de la sant&#xE9; et de la soci&#xE9;t&#xE9; civile (FERASCOM). Ces acteurs ont restitu&#xE9; le contenu de ces plans aux acteurs r&#xE9;gionaux et certains ont valid&#xE9; leurs plans avec les acteurs communautaires (medecins chef de districts, services locaux de d&#xE9;veloppement social, soci&#xE9;t&#xE9; civile)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IEC materials developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique a l&apos;&#xE9;laboration du plan strat&#xE9;gique national de communication et de plans int&#xE9;gr&#xE9;s de communication et appuyer leur mise en place dans les DS prioritaires 
Apporter un appui technique pour le fonctionnement et le suivi des cadres e redevabilite dans les districts prioritaires
Actualiser/&#xE9;laborer des messages et supports de communication pour le PEV de routine
Documenter les bonnes pratiques sur l?engagement communautaire pour le PEV : Vid&#xE9;os/ articles/photographie de qualit&#xE9; ;">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Du 14 au 20 juin, l&apos;UNICEF a appuy&#xE9; l&apos;unit&#xE9; PEV pour organiser un atelier sur le d&#xE9;veloppement de messages et la production de mat&#xE9;riel IEC sur la vaccination de routine. Les participants venaient de la direction r&#xE9;gionale de la sant&#xE9;, de la direction r&#xE9;gionale du d&#xE9;veloppement social de Bamako, Kayes, Sikasso, Mopti, Segou, Gao, Tumbuktu, ainsi que des sp&#xE9;cialistes C4D et PEV des bureaux de l&apos;UNICEF de Tumbuktu, Gao, Kayes, Sikasso, Mopti. L&apos;atelier a &#xE9;t&#xE9; facilit&#xE9; par le sp&#xE9;cialiste C4D et le sp&#xE9;cialiste PEV de l&apos;UNICEF en collaboration avec la CNIECS, la cellule PEV, la direction nationale du d&#xE9;veloppement social, l&apos;OMS, AEDES. A l&apos;issue de l&apos;atelier les scripts de 6 spots radio et TV, 3 scripts de sketchs, 3 d&#xE9;pliants sur le PEV et la surveillance communautaire, la description des nouvelles images sur le HPV, le calendrier de vaccination avec le 6&#xE8;me contact, l&apos;engagement des hommes dans la vaccination de leurs enfants, ont &#xE9;t&#xE9; valid&#xE9;s. Une &#xE9;quipe technique est en train de finaliser les delivrables et un pr&#xE9;-test de tout le mat&#xE9;riel sera fait dans les communaut&#xE9;s bient&#xF4;t. La prochaine &#xE9;tape sera un atelier de validation du mat&#xE9;riel.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and mechanisms to assess and monitor quality and acceptance of services developed and in use by countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du suivi des cadres de redevabilite et particulierement les plateformes urbaines de soutien a la vaccination dans les 06 Communes du Distict de Bamako ainsi aue l&apos;utilisation des echeanciers pour la reduction du notaux d&apos;abandon.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Pour ameliorer la generation de la demande, des cadres des redevabilite ont ete mis en place dans les communes. Un suivi trimestriel des engagements est realise a travers une mission conjointe composee des representants du PEV, de DRDES, la DRS et la Direction regionale de la Promotion de la Femme, de l&apos;Enfant et de la Famille et leurs services locaux respectifs et du District Sanitaire. Les engagements suivis dans ce cadres sont: 1) - Pour les equipes CSCom: la disponibilite quotidienne de la vaccination en Centre Fixe, l&apos;etablissement du planning mensuel de la SA et le partage avec les Femmes Leaders pour la mobilisation Sociale, la realisation de la SA ciblee, l&apos;utilisation efficiente du systeme echeancier dont l&apos;etablissement du nombre et de la liste mensuels des enfants manques en vue de leur recherche active. 2) - Pour les Femmes Leaders: la realisation des VAD conformement aux plannings etablis en debut de mois et la recuperation des enfants non vaccines, la realisation des causeries educatives dans les secteurs selon le plan mensuel etabli, le partage de l&apos;information sur le calendrier des sorties en SA et la mobilisation sociale au cours des seances de vaccination et la recherche active des enfants manques selon la liste mensuelle emanant des equipes de vaccination.3) - Pour l&apos;Association de sante communautaire: l&apos;appui financier aux activites de soutien a la vaccination, l&apos;appui aux activites de communication et de mobilisation Sociale, l&apos;appui a la fonctionnalite des comites de suivi des cadres de redevabilite aire de sante. Ces differents dispositifs ont permis de couvrir beaucoup d&apos;enfants oublies tels les enfants des aides-menageres, les enfants des PDIs comme l&apos;attestent le nombre des enfants supplementaires vaccines au Penta1, le taux de CV du Penta 3, l&apos;amelioration du taux d&apos;abandon Penta1-Penta3 et l&apos;augmentation du taux de CV du VAR2 qui avait du mal a decoller qui a evolue de 20% de janvier a septembre 2020 a 59% pour la meme periode en 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement de la mise en oeuvre et le suivi des interventions pro-equite adaptees au milieu urbain dans les 06 Communes du District de Bamako et assurer le suivi de l&apos;extension de la strategie urbaine aux villes de Kayes, Sikasso, Mopti et Segou.">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Au cours du 1er semestre 2021, des analyses des goulots d&apos;&#xE9;tranglement ont &#xE9;t&#xE9; faites lors des ateliers d?actualisation des microplans dans les diff&#xE9;rentes communes de Bamako grace a l?utilisation de l&apos;outil d&apos;analyse des goulots d&apos;&#xE9;tranglement (annexe outil commune 6
Un travail sur les obstacles li&#xE9;s a la prestation des services de vaccination en milieu urbain a &#xE9;t&#xE9; fait et a permis de classer les obstacles selon leurs priorit&#xE9;s comme suit : 
i) l?engagement communautaire en faveur des services de vaccination reste insuffisant et a besoin d&apos;&#xEA;tre &#xE9;troitement suivi ; 
ii) le conflit d&apos;agenda entre les horaires de vaccination et les occupations des mamans/gardiennes d&apos;enfants iii) le mauvais accueil qui a &#xE9;t&#xE9; confirm&#xE9; par les mini-enqu&#xEA;tes men&#xE9;es par les Femmes Leaders lors des VAD et des causeries &#xE9;ducatives 
Aussi, les communaut&#xE9;s difficiles d&apos;acc&#xE8;s (communaut&#xE9;s des collines, sur les iles et les bords du fleuve Niger qui traverse Bamako, p&#xE9;ri-urbaines parfois non couvertes par une aire de sante, les marchandes qui passent toute la journ&#xE9;e dans les marches et les gares routi&#xE8;res et les Personnes D&#xE9;plac&#xE9;es Internes qui vivent sur trois sites en Commune 6 du District de Bamako) ont &#xE9;t&#xE9; aussi r&#xE9;pertori&#xE9;s et couverts par les services de vaccination. 
Les donn&#xE9;es de vaccination de jan-mai ont connu une &#xE9;volution croissante dans les 06 Communes du District de Bamako entre 2020 et 2021. En effet: 
?	Commune 1 : Penta 1 (9564 vaccines sur 8130 en 2021 contre 8923 en 2020 
?	Commune II, 3,730 (97%) vaccin&#xE9;s sur 3,875 contre 3,382 en 2020 soit 90% (145 z&#xE9;ro dose en 2021 contre 383 en 2020). 
?	Commune III, 3,194 vaccines sur 3,115 (104%) en 2021 contre 2,792 en 2020 (92%). Aucun enfant z&#xE9;ro en 2021 contre 248 enfants zero dose en 2020
?	Commune IV a enregistr&#xE9; sur 7,275 en 2021, 8,567 enfants vaccines au Penta1 (119%) contre 7,146 doses administr&#xE9;es sur la m&#xEA;me p&#xE9;riode en 2020 (101%). 
?	Toutes les Communes de Bamako affichent plus de 90% de CV au Penta1 et Penta3</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer a la mise en oeuvre des strategies visant l&apos;amelioration de la couverture et l&apos;equite dns la vaccination dans les districts prioritaires des regions de Kayes, Sikasso, Mopti et Segou,">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Dans tous les districts prioritaires des regions de Kayes, Sikasso, Mopti et Segou, le travail a consiste a mettre a jour les microplans elabores en 2020. Une analyse basee sur l&apos;equite dans la vaccination a ete conduite qui a permis d&apos;identifier notamment les goulots suivants: Kenieba et Kayes, la mobilite de la population a cause de la multiplicite des sites d&apos;orpeillage a ete identifiee comme un grand obstacle a l&apos;acces aux services de vaccination; il a ete mentionne aussi les obstacles naturels avec des montagnes tres eleves qui empechent la population d&apos;acceder aux services de vaccination. Avec les approches identifiees pour lever ces goulots, il a ete constate une reduction des enfants zero dose de de 2519 de janvier a septembre 2020 a 1405 enfant zero dose pour la meme periode en 2021. Dans la region de Sikasso, l&apos;analyse faite a montre que dans presque tous les districts, une y avait une faible realisation des seances en strategies fixes et avancees; l&apos;amelioration de la disponibilite des services de vaccination avec l&apos;augmentation des nombres des seances de vaccination a permis de reduire le nombre d&apos;enfants zero dose dans laplupart des districts de la region (cfr tableau zero dose region de Sikasso). Dans les regions de Mopti et Segou, c&apos;est l&apos;insecurite et parfois certains obsatcles naturelles comme la montee d&apos;eau pendnat une certaine periode de l&apos;annee qui a ete identifie comme principaux obstacles. Comme pour Yorosso ou le faible esance de realisation etait duea l&apos;inecurite, le recrutement local des agents vaccinateurs et l&apos;utilisation des relais des villages a permis de reduire le nombre d&apos;enfants zero dose</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer a la mise en oeuvre des strategies visant l&apos;amelioration de la couverture et l&apos;equite dns la vaccination dans les districts prioritaires des regions de Kayes, Sikasso, Mopti et Segou,">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En f&#xE9;vrier 2021, les districts des r&#xE9;gions de Sikasso, Kayes, Mopti et S&#xE9;gou ont mis &#xE0; jour leurs microplans avec des activit&#xE9;s issues des plans d?am&#xE9;lioration orient&#xE9;es vers les communaut&#xE9;s d&apos;acc&#xE8;s difficile. Le District de Sikasso a m&#xEA;me identifi&#xE9; des activit&#xE9;s pour la vaccination en milieux urbains. La mise en ?uvre des activit&#xE9;s identifi&#xE9;es dans la strat&#xE9;gie urbaine qui sont en cours de mises en ?uvre dans les deux CSComs urbains notamment l?&#xE9;largissement aux structures confessionnelles avec la cr&#xE9;ation d?un centre de vaccination au dispensaire catholique dans l&apos;aire de sant&#xE9; de Sanoubougou 1 pour atteindre les populations p&#xE9;ri-urbaines parfois non prises en compte dans la planification.
Les r&#xE9;sultats obtenus aux cours des 4 premiers mois au niveau des diff&#xE9;rents districts y compris les districts prioritaires montrent une couverture administrative penta 1 sup&#xE9;rieure ou &#xE9;gale &#xE0; 90% &#xE0; l&apos;exception de Kignan (77%) et de Niena (83%) qui ont encore des enfants z&#xE9;ro dose respectivement de 241 et 117. On note que 100% des districts prioritaires ont une couverture penta 3 sup&#xE9;rieure ou &#xE9;gale &#xE0; 90% et sur l?ensemble de la r&#xE9;gion, 75% des districts ont atteint au moins les 90% de taux de couverture en penta 3 
Au niveau de la r&#xE9;gion de Kayes, ce sont des grands sites d?orpaillages traditionnels des districts prioritaires de Kayes, de Kenieba et de Kita qui ont &#xE9;t&#xE9; identifi&#xE9;s et la vaccination a &#xE9;t&#xE9; men&#xE9;es en faveur des enfants manqu&#xE9;s. 100% des districts prioritaires (6 pour une r&#xE9;gion qui en compte 10) ont plus de 90%. Aussi, on a not&#xE9; qu?en fin avril 2020, il y avait 2029 enfants z&#xE9;ro dose au niveau r&#xE9;gional, contre 857 enfants z&#xE9;ro dose pour la m&#xEA;me p&#xE9;riode en 2021
Au niveau de la r&#xE9;gion de S&#xE9;gou, ce sont les enfants qui vivent le long du fleuve qui ont &#xE9;t&#xE9; identifi&#xE9;s et vaccin&#xE9;s. Ainsi, en 2020 on a not&#xE9; qu?il y avait 374 enfants z&#xE9;ro dose ; en 2021, plus de 2430 enfants ont &#xE9;t&#xE9; vaccin&#xE9;s au-del&#xE0; de la cible</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and approaches developed to improve and sustain quality and safety of immunisation services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement de la mise en oeuvre et le suivi des interventions pro-equite adaptees au milieu urbain dans les 06 Communes du District de Bamako et assurer le suivi de l&apos;extension de la strategie urbaine aux villes de Kayes, Sikasso, Mopti et Segou.">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Pour mettre a jour des microplans equite en milieu urbain de Bamako, un Canevas d&apos;evaluation des obstacles lies aux services de vaccination a ete concu et utilise en 2021 et ,renseigne par chaque CSCom. L&apos;identification des obstacles au cours de l&apos;analyse a ete actualisee. Cet exercice a abouti a reconduire/renforcer ou innover les strategies retenues notamment : la vaccination quotidienne en fixe ; gratuite de la carte de vaccination ; maintien de la SA ciblee sur les communautes particulieres (PDIs, campements bozos pecheurs) et difficile d&apos;acces (sur les collines et dans les zones peri-urbaines) pour recuperer les enfants; le renforcement du systeme echeancier; reperage mensuel systematique des enfants manques, et repartition des enfants a rechercher par secteur entre les Femmes Leaders, mise en place et fonctionnement du comites de suivi du cadre de redevabilite au niveau de chaque aire de sante, suivi trimestriel conjoint PE/PTF des engagements contenus dans les cadres de redevabilite. Ce disposif a permis une nette amelioration des indicateurs de janvier a septembre 2021 par rapport a leurs niveaux de 2020. Ainsi, de facon globale, l&apos;amelioration de l&apos;acces aux services de vaccination qui sont devenus tres accueillants a permis au District de Bamako, entre janvier et septembre 2021, de vacciner 100, 965 enfants de 0-11 mois au Penta1 dont plus de 22,000 enfants supplementaires par rapport a la cible de la meme periode contre 87,827 dont 11,066 enfants supplementaires par rapport a la cible en 2020. L&apos;utilsation des services de vaccination a aussi connu une nette amelioration avec 94,194 enfants de 0-11 mois vaccines au Penta3, 92,727 enfants 0-11 mois au VAR1 de janvier a septembre 2021 contre 80,729 au Penta3 et 74,758 au cours de la meme periode en 2021. Par ailleurs, le District de Bamakoa enregistre 120% de CV Penta3 en 2021 contre 101% en 2020 avec un taux d&apos;abandon Penta1/Penta3 de 7% en 2021 contre 9% en 2020; .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documents de soumission pour l&apos;HPV sont &#xE9;labor&#xE9;s, valid&#xE9;s et soumis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?introduction de nouveaux vaccins (HPV)">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Documents de soumission &#xE9;labor&#xE9;s et soumis dans la plateforme.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils de gestion, modules de formation et plans d&apos;introduction et de communication sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?introduction de nouveaux vaccins (HPV)">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Documents de soumission &#xE9;labor&#xE9;s et soumis dans la plateforme.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;union (de consensus) des parties prenantes organis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?introduction de nouveaux vaccins (HPV)">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Documents de soumission &#xE9;labor&#xE9;s et soumis dans la plateforme.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% de postes de vaccination alimentent &#xE0; temps le registre &#xE9;lectronique en utilisant les tablettes acquises et produisent le rapport mensuel en utilisant le tableau de bord</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du registre &#xE9;lectronique de la vaccination  dans le DHIS2 et des tableaux de bord de couverture et gestion des vaccins (DVD/SMT)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Attente de la requ&#xEA;te du Minist&#xE8;re de la Sant&#xE9; pour le d&#xE9;ploiement de l&apos;assistant technique.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du registre &#xE9;lectronique de la vaccination  dans le DHIS2 et des tableaux de bord de couverture et gestion des vaccins (DVD/SMT)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Attente de la requ&#xEA;te du Minist&#xE8;re de la Sant&#xE9; pour le d&#xE9;ploiement de l&apos;assistant technique.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du registre &#xE9;lectronique de la vaccination dans le DHIS2 et des tableaux de bord de couverture et gestion des vaccins (DVD/SMT)">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Le processus de d&#xE9;ploiement est en cours, l?acquisition des tablettes est effective et les formations sont planifi&#xE9;es.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% de postes de vaccination alimentent &#xE0; temps le registre &#xE9;lectronique en utilisant les tablettes acquises et produisent le rapport mensuel en utilisant le tableau de bord</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du registre &#xE9;lectronique de la vaccination dans le DHIS2 et des tableaux de bord de couverture et gestion des vaccins (DVD/SMT)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En attente de la requ&#xEA;te du minist&#xE8;re de la sant&#xE9; pour le d&#xE9;ploiement de l&apos;assistance technique</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;duction de l?&#xE9;cart entre les couvertures administratives et d?estimations OMS UNICEF de 23 en 2017 &#xE0; 13 points</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;amelioration de la qualite des donnees par la mise en place de mecanisme de suivi  par: 
 1) La mise  en place un mecanisme de suivi des r&#xE9;unions mensuelles d?harmonisation et de validation des donn&#xE9;es entre les DTC et l?&#xE9;quipe cadre du district. 
 2) La conduite  des supervisions conjointes da la qualit&#xE9; des donn&#xE9;es-
 3) L&apos;elaboration  avec les acteurs des tableaux de bord pour le suivi des indicateurs.
4)  L&apos;elaboration p&#xE9;riodique des rapport de synth&#xE8;se des travaux de la sous comission charg&#xE9; du suivi de la qualit&#xE9; des donn&#xE9;es.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Participation aux r&#xE9;unions du groupe qualit&#xE9; des donn&#xE9;es avec production des rapports, aux missions conjointes de suivie.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;amelioration de la qualite des donnees par la mise en place de mecanisme de suivi  par: 
 1) La mise  en place un mecanisme de suivi des r&#xE9;unions mensuelles d?harmonisation et de validation des donn&#xE9;es entre les DTC et l?&#xE9;quipe cadre du district. 
 2) La conduite  des supervisions conjointes da la qualit&#xE9; des donn&#xE9;es-
 3) L&apos;elaboration  avec les acteurs des tableaux de bord pour le suivi des indicateurs.
4)  L&apos;elaboration p&#xE9;riodique des rapport de synth&#xE8;se des travaux de la sous comission charg&#xE9; du suivi de la qualit&#xE9; des donn&#xE9;es.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Participation aux r&#xE9;unions du groupe qualit&#xE9; des donn&#xE9;es avec production des rapports, aux missions conjointes de suivie.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La soumission est elabor&#xE9;e , valid&#xE9;e et soumise a Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a l?application RSS (JSP)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non encore planifi&#xE9;e par le Minist&#xE8;re de la Sant&#xE9; en raison des activit&#xE9;s de vaccination contre la COVID-19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a l?application RSS (JSP)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non encore planifi&#xE9;e par le Minist&#xE8;re de la Sant&#xE9; en raison des activit&#xE9;s de vaccination contre la COVID-19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a l?application RSS (JSP)">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">La soumission a &#xE9;t&#xE9; report&#xE9;e au premier trimestre 2022 suite &#xE0; l&apos;extension du RSS 2 au 31 d&#xE9;cembre 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;activitie est conduite avec rapport disponible avec plan de mise en oeuvre des recommandations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a la pr&#xE9;paration de la revue externe du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le PPAC 2022-2026 valid&#xE9; par le CCIA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAC 2022-2026">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAC 2022-2026">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAC 2022-2026">
      <location ref="ML"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Le PPAc a &#xE9;t&#xE9; remplac&#xE9; par la Strat&#xE9;gie Nationale de Vaccination qui n&#xE9;cessit&#xE9; d&apos;abord la finalisation de la revue externe du PEV et dont les pr&#xE9;paratifs sont en cours dans le pays.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 30 % des recommandations sont mises en oeuvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a la pr&#xE9;paration de la revue externe du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a la pr&#xE9;paration de la revue externe du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; and generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Despite COVID-19 and ongoing security issues, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Mali as a strategic country at high risk for meningitis disease and epidemics. In 2020, surveillance system health was monitored, and technical assistance provided remotely through monthly teleconferences during the pandemic shutdown. In 2021, Mali has participated in five MenAfriNet Surveillance &amp; Data Management Work Group meetings, and shared meningitis surveillance data weekly to inform epidemic situation monitoring. Between January-June 2021, Mali reported 173 cases but experienced no meningococcal epidemics, and Streptococcus pneumoniae was the dominant meningitis pathogen confirmed thus far in 2021. Validation of 2020 meningitis surveillance data has been delayed due to COVID-19, but is planned to be completed in Q3-4 2021. An evaluation of the national meningitis surveillance variables was completed in support of WHO/country plans for pilot implementation of DHIS2 meningitis case-based surveillance module. This has been delayed due to COVID-19, but planned for later in 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Despite COVID-19 and ongoing security issues, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Mali as a strategic country at high risk for meningitis disease and epidemics. In 2020, surveillance system health was monitored, and technical assistance provided remotely through monthly teleconferences during the pandemic shutdown. In 2021, Mali has participated in five MenAfriNet Surveillance &amp; Data Management Work Group meetings, and shared meningitis surveillance data weekly to inform epidemic situation monitoring. Between January-June 2021, Mali reported 173 cases but experienced no meningococcal epidemics, and Streptococcus pneumoniae was the dominant meningitis pathogen confirmed thus far in 2021. Validation of 2020 meningitis surveillance data has been delayed due to COVID-19, but is planned to be completed in Q3-4 2021. An evaluation of the national meningitis surveillance variables was completed in support of WHO/country plans for pilot implementation of DHIS2 meningitis case-based surveillance module. This has been delayed due to COVID-19, but planned for later in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of national and &gt;2 regional reference labs on detection of bacterial meningitis using the latest effective technology; Implement in-country programs to ensure lab proficiency within the lab network; Complete analysis of &gt;90% of specimens collected between Jan-Aug 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, meningitis surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3)improve specimen management systems; 4) improve lab data management, analysis, and reporting practices.">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">In-country PT panels were sent to districts as part of quality programs in January 2020. Supervisory visits for sites that did not pass PT were conducted in February 2020. Trainings in district of Bamako, Kaves and Koulikoro were conducted in July 2020.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits at least 5 sites; Pilot a specimen management system to effectively track specimen transport and testing; Complete analysis &gt;90% of specimens collected in 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, meningitis surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3)improve specimen management systems; 4) improve lab data management, analysis, and reporting practices.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. While Mali was not able to complete all activities by June 2021 due to in-country security issues, they will complete activities by December 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, meningitis surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3)improve specimen management systems; 4) improve lab data management, analysis, and reporting practices.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. While Mali was not able to complete all activities by June 2021 due to in-country security issues, they will complete activities by December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La r&#xE9;union de consensus avec le MS et partenaires est r&#xE9;alis&#xE9;e et les TDR des activites , le chronogramme sont valides et les ressources( Humaines et financieres sont identifies)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a l?application RSS (JSP)">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non encore planifi&#xE9;e par le Minist&#xE8;re de la Sant&#xE9; en raison des activit&#xE9;s de vaccination contre la COVID-19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les appuis techniques sont identifi&#xE9;s et deployes au Mali</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a l?application RSS (JSP)">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Il y&apos;a eu une prolongation du RSS en cours, les pr&#xE9;paratifs de la nouvelle soumission sont en cours notamment ceux relatifs &#xE0; la revue externe du PEV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">x% of NITAG meetings held and z% of NITAG recommendations implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le fonctionnement des organes de coordination et de gouvernance notamment&#xA0; le GTCV, le Comit&#xE9; des experts MAPI">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;appui continue aux deux organes</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le fonctionnement des organes de coordination et de gouvernance notamment&#xA0; le GTCV, le Comit&#xE9; des experts MAPI">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un soutien technique est apport&#xE9; afin d&apos;ameliorer la couverture de la vaccination de
routine et renforcer les systemes de vaccination de routine.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement g&#xE9;n&#xE9;rale du PEV par le soutien du NPO Routine immunisation">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;appui continue en terme de renforcement &#xE0; la section immunisation dans la coordination suivi et monitorage des activit&#xE9;s de vaccination. Concernant le suivi un bulletin mensuel est produit avec partage aux parties prenantes.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le programme national de vaccination est appuye&#xE9; &#xE0; integrer les
politiques et strategies regionales et mondiales de vaccination dans la Strategie de cooperation pays.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement g&#xE9;n&#xE9;rale du PEV par le soutien du NPO Routine immunisation">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Le renforcement des programmes nationaux de vaccination continu, notamment la vaccination de routine, l&apos;introduction des nouveaux vaccins et les activit&#xE9;s de vaccination suppl&#xE9;mentaires, conform&#xE9;ment aux directives techniques en vigueur afin de r&#xE9;duire la morbidit&#xE9; et la mortalit&#xE9; dues aux maladies &#xE9;vitables par la vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;exp&#xE9;rience est partag&#xE9;e avec d&apos;autres districts et r&#xE9;gions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du leadership et de la gouvernance des FENASCOM de Kayes avec focus sur les ASACO des districts prioritaires en collaboration avec la FENASCOM">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">le plan d&apos;action du renforcement est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du leadership et de la gouvernance des FENASCOM de Kayes avec focus sur les ASACO des districts prioritaires en collaboration avec la FENASCOM">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;union de consensus avec les parties prenantes est tenue, TDR du consultant elabor&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;enqu&#xEA;te de couverture vaccinale par le deployement d&apos;une assistance technique">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non encore planifi&#xE9;e par le Minist&#xE8;re de la Sant&#xE9; en raison des activit&#xE9;s de vaccination contre la COVID-19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le consultant est identifi&#xE9; pour appuyer&#xA0; l&apos;&#xE9;valuation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;enqu&#xEA;te de couverture vaccinale par le deployement d&apos;une assistance technique">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Le consultant national est identifi&#xE9; et recrut&#xE9; depuis le 01 novembre.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">* Le taux d&apos;abandon specifique penta est de reduit de 5 points de pourcentage par rapport a 2019. *Au moins 50% d&apos;enfants perdus de vue &#xE2;g&#xE9;s de moins de 1 an ont &#xE9;t&#xE9; r&#xE9;cup&#xE9;r&#xE9;s dans les r&#xE9;gions de Gao, Mopti, Tombouctou et Kidal</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la coordination et le suivi de la mise en ?uvre des strat&#xE9;gies de vaccination dans les districts prioritaires de la r&#xE9;gion du centre (Macina, Niono, Mopti et Djenne) et dans les r&#xE9;gions du nord touch&#xE9;es par l?ins&#xE9;curit&#xE9;:- Participer &#xE0; l?analyse de la situation s&#xE9;curitaire et identifier des strat&#xE9;gies (couloirs) pour atteindre les cibles de la vaccination. - Apporter un appui technique &#xE0; l?&#xE9;laboration de la cartographie sociale des intervenants potentiels en vaccination dans les zones de conflit aussi bien au niveau des districts prioritaires qu?au niveau des aires de sante - Assurer la coordination des ONG intervenant dans la vaccination dans les zones de conflit (centre et nord) - Apporter un appui technique a l?&#xE9;laboration des microplans et cadres logiques des ONG intervenant dans les zones de conflit - Apporter un appui technique &#xE0; la programmation des strat&#xE9;gies de vaccination en situation de conflit (PIRI,SIAS) - apporter un appui a la negociation pour la vaccination en zones de conflit - Apporter un appui technique &#xE0; l?analyse des donn&#xE9;es de vaccination des intervenants sur terrain - Contribuer &#xE0; la mise en place d?un cadre de suivi et de monitorage des interventions orient&#xE9;es vers les communaut&#xE9;s difficiles d?acc&#xE8;s. - Faire le suivi trimestriel des tableaux de bord et des goulots d?&#xE9;tranglements du syst&#xE8;me de vaccination des districts prioritaires">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Malgre la situation d&apos;insecurite dans la region de Mopti avec meme la delocalisation de l&apos;appui vers la region de Segou, on note une legere reduction du taux d&apos;abandons specifique qui passe de 17 a 15% grace a l&apos;action des membres de mise en place des cadres de redevabilite dans deux districts (Djene et Mopti). les districts de Badjangara et Tenenkou ont aussi ameliore leur performance (CV entre 80-90%) grace au suivi communautaire.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">CDC is working with in-country partners on operational plans to implement activities and establish timelines. Standardized programs with a focus on laboratory quality measures are being developed to ensure lab quality and proficiency.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Generation of routine meningitis surveillance performance feedback summaries to guide national monitoring and evaluation, with a target of &gt;90% of participating districts reporting data quarterly and &gt;70% of suspected meningitis cases have a specimen collected</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management and integration into broader health information systems (i.e. DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between disease surveillance and immunization, use of data at country-level to guide meningitis vaccine programs; 3) reinforce the country&apos;s capacity for epidemic detection and response, harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile); 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Mali is participating in MenAfriNet Surveillance &amp; Data Management Work Group meetings as well as activity work planning in June &amp; November 2021--a review of data management and specimen transport system completeness and timeliness was completed in Q3 2021. Mali continued to host quarterly meetings with in-country implementing partners supporting 2021 workplan activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Review of data management and specimen transport system efficiency and update on integration status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management and integration into broader health information systems (i.e. DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between disease surveillance and immunization, use of data at country-level to guide meningitis vaccine programs; 3) reinforce the country&apos;s capacity for epidemic detection and response, harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile); 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Mali is participating in MenAfriNet Surveillance &amp; Data Management Work Group meetings as well as activity work planning in June 2021. A review of data management and specimen transport system completeness and timeliness will be completed in Q3 2021. Mali will continue to host quarterly meetings with in-country implementing partners supporting 2021 workplan activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at national lab for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Mali under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Meningitis bacteriology diagnostics testing training was completed in July 2021 at the INSP in Bamako, where 12 laboratory staffs from Bamako (1) and health districts (11) from five regions (Kayes, Koulikoro, S&#xE9;gou, Sikasso and Mopti) have been trained. On-site &quot;Coaching&quot; training was completed in August 2021. Supervisory visits were conducted in August and September 2021. Due to security issues, one of the 12 previous trained sites was not visited. Two supervisors for each of the five regions received a questionnaire to verify the availability and compliance with operating procedures for the meningitis diagnostics and CSF conditioning; these questionnaires were sent to the national reference lab.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux districts des regions de Kayes, Sikasso, Mopti et Segou &#xE0; l?analyse des donn&#xE9;es du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Au cours de ce premier semestre, les revues des donnees ont ete appuyees non seulement au niveau des districts prioritaires mais aussi das les autres districts. Un exercice de triangulation a realise dans le district de Kati dans deux aires de sante a donne des resultats suivants: Lors de la visite de terrain &#xE0; Kita r&#xE9;alis&#xE9;e en f&#xE9;vrier 2021, la situation suivante a &#xE9;t&#xE9; analys&#xE9;e :
Aire de sante de Goro : stock de penta d&#xE9;but : 50doses ; Stock re&#xE7;u 150 doses soit 200 doses disponibles avec 180 enfants vaccines au penta
Aire de Sante de Sirakore en janvier 2021 : l?analyse faite en comparant les enfants vaccin&#xE9;s &#xE0; la couverture sur le DHIS2 : pour une cible de 62 enfants, 44 enfants vaccines mais la couverture retrouv&#xE9;e dans le DHIS2 donne 158% avec les m&#xEA;mes couvertures de 158% en penta 3, VAR1 
Cette situation a &#xE9;t&#xE9; restitu&#xE9;e a l?&#xE9;quipe cadre, car malgre les plus de 100% en VAR, l?aire de sante &#xE9;tait en &#xE9;pid&#xE9;mie de rougeole</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique &#xE0; l?amelioration de la qualite des donnees de vaccination au niveau des 06 Communes du District de Bamako.">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;&#xE9;valuation de la qualit&#xE9; des donn&#xE9;es de vaccination a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e au cours des ateliers de revue/validation des donn&#xE9;es et qui a port&#xE9; sur la compl&#xE9;tude/promptitude des donn&#xE9;es, la coh&#xE9;rence interne, la concordance des doses des vaccins administr&#xE9;s concomitamment, la triangulation des enfants vaccines avec les doses de vaccins utilis&#xE9;es et les donn&#xE9;es de surveillance &#xE9;pid&#xE9;miologique de la rougeole. 
Les diff&#xE9;rents obstacles &#xE0; l&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es identifi&#xE9;s au cours de la derni&#xE8;re revue des donn&#xE9;es de 2020 sont: la non maitrise de la population, l&apos;insuffisance dans le remplissage des diff&#xE9;rents supports (registre de vaccination, registre de pointage, fiches &#xE9;ch&#xE9;anciers rapports journaliers/mensuels de vaccination, cahier de stock des vaccins et consommables), l&apos;insuffisance de communication entre les Charges PEV et SIS, la grande mobilit&#xE9; des enfants entre les CSCom (la plupart des CSCom vaccinent aussi les hors aire, la m&#xE9;connaissance des hors cible...). Ainsi pour am&#xE9;liorer de fa&#xE7;on durable la qualit&#xE9; des donn&#xE9;es de vaccination, nous avons initi&#xE9; l&apos;accompagnement des CSCom pour un meilleur remplissage des supports primaires d&#xE9;bouchant sur un rapport mensuel correct 
R&#xE9;sultats : Au total, 37 cas de rougeole ont &#xE9;t&#xE9; confirm&#xE9;s au laboratoire de janvier &#xE0; mai 2021 dans le District de Bamako, soit une incidence de 1,7 pour 100,000 habitants. Les communes qui sont free de rougeole sont celles qui ont am&#xE9;lior&#xE9; leur couverture en VAR1 et 2 (la Commune V a enregistr&#xE9; 93% VAR1 et 20% VAR2 en 2020 contre 103% VAR1 et 59% VAR2 en 2021 ; la Commune VI a enregistr&#xE9; 124% VAR1 et 13% VAR2 en 2020 contre 143% VAR1 et 98% VAR2 en 2021). Alors que les Communes II et III avec respectivement 5 et 3 cas de rougeole ont vaccine respectivement 78% au VAR1 et 3% au VAR2 en 2020 contre 88% au VAR1 et 17% au VAR2 en 2021 ; et 85% de CV VAR1 et 5% au VAR2 en 2020 contre 88% au VAR1 et 27% au VAR2 en 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique &#xE0; l?amelioration de la qualite des donnees de vaccination au niveau des 06 Communes du District de Bamako.">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Pour am&#xE9;liorer la qualit&#xE9; des donn&#xE9;es de vaccination, un plan d&apos;analyse/revue des donn&#xE9;es a &#xE9;t&#xE9; utilis&#xE9; au niveau de toutes les Communes de Bamako. Chaque commune g&#xE9;n&#xE8;re , &#xE0; partir du DHIS2, les donn&#xE9;es et lors de la pl&#xE9;ni&#xE8;re, le plan d&apos;analyse est pass&#xE9; en revue et chaque item est comment&#xE9; par les producteurs de ces donn&#xE9;es que sont les DTC, charg&#xE9;s PEV et charg&#xE9;s SIS). 
Chaque &#xE9;quipe rel&#xE8;ve les insuffisances constat&#xE9;es au niveau de sa structure et y apporte des corrections ; ensuite, un tableau fait la synth&#xE8;se des corrections, les causes probables des erreurs sont discut&#xE9;es et une proposition d&apos;am&#xE9;lioration est faite. Ceci permet aux diff&#xE9;rents acteurs de s&apos;approprier de la qualit&#xE9; des donn&#xE9;es qu&apos;ils g&#xE9;n&#xE8;rent et renforce leur redevabilit&#xE9;. 
Ensuite, on analyse la Compl&#xE9;tude/promptitude des donn&#xE9;es, la performance du syst&#xE8;me de vaccination (s&#xE9;ances r&#xE9;alis&#xE9;es et total vaccin&#xE9;s par antig&#xE8;ne et par strat&#xE9;gie, les z&#xE9;ro doses et les sous-vaccin&#xE9;s, l&apos;&#xE9;volution des CV Penta1, Penta3, VAR1 et VAR2 entre l&apos;ann&#xE9;e en cours compar&#xE9;es a l?ann&#xE9;e pr&#xE9;c&#xE9;dente, l&apos;&#xE9;volution du taux d&apos;abandon Penta1-Penta3, Penta1-VAR1 et VAR1-VAR2 compar&#xE9;e l?ann&#xE9;e pr&#xE9;c&#xE9;dente pour la m&#xEA;me p&#xE9;riode et des ruptures de stock en antig&#xE8;ne sont aussi relev&#xE9;es. L&apos;analyse concerne aussi la concordance des doses de vaccins administr&#xE9;es concomitamment, la triangulation des donn&#xE9;es entre le nombre de doses administr&#xE9;es, le nombre de doses disponibles et le nombre de doses utilis&#xE9;es. 
Dans l&apos;analyse de janvier amai 2021 (execrcie en cours pour juin a septembre), dans les 06 Communes de Bamako, la plupart des erreurs &#xE9;taient dues &#xE0; l&apos;inattention au moment de la saisie dans le DHIS2. Cependant, des &#xE9;carts de triangulation ont &#xE9;t&#xE9; constat&#xE9;es. A titre illustratif, dans quelques CSCom dont ASACODJE, durant les cinq mois sous revue, 5,268 enfants ont &#xE9;t&#xE9; vaccin&#xE9;s avec 2,660 doses de Penta et 1687 enfants ont &#xE9;t&#xE9; vaccines avec 920 doses de VAR.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux districts des regions de Kayes, Sikasso, Mopti et Segou &#xE0; l?analyse des donn&#xE9;es du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Pour ce qui est de la qualite des donnees dans les regions de Segou, Kayes, Sikasso, Mopti, ce sont les revues des donees de vaccination avec la participation des acteurs du niveau national qui a permis d&apos;idnetifier certaines aberrations et les erreurs commises lors des saisies d donnees. Dans certaines regions comme Sikasso, une triangulation entre donnees de gestion des vaccins et donnees d&apos;enfants vaccines a permis de constater qu&apos;l n&apos;y a pas d&apos;enfants vaccines au dela des doses de vaccins disponibles mais seulement un taux de perte eleve (cfr Rapport revue Sikasso) surtout dans les districts de Kadiolo</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AEDES : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Number of quality WG meetings with minutes containing monitoring of data quality indicators</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support management of immunization data:">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Pas de tenue de r&#xE9;unions du Groupe Qualit&#xE9; des donn&#xE9;es</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for implementing digitization of registers</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support management of immunization data:">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Processus reprogramm&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Revised supervision tools</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support management of immunization data:">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Processus reprogramm&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; User guide for dashboards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support management of immunization data:">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to and attendance at NITAG, ICC, and related meetings is completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in NITAG, ICC and other related meetings to discuss decision making for HPV introduction and pathway forward for application to Gavi">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">All three required signatures are now available and the application is now complete (signatures of the Minsiters of Health, Finance and Education). The application will be reviewed by the IRC during the next round in January.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in NITAG, ICC and other related meetings to discuss decision making for HPV introduction and pathway forward for application to Gavi">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in HPV TWG meetings.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in NITAG, ICC and other related meetings to discuss decision making for HPV introduction and pathway forward for application to Gavi">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in HPV TWG meetings.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in JA completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in Gavi&apos;s annual Joint Appraisal and grant renewal processes to ensure continuity of HPV TA support">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">PATH remotely participated in the MSD dialogues in 2020.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised HPV application submitted to Gavi, as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with revisions of HPV application, after review by Gavi, if necessary">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Application will not be reviewed by IRC until Jan. 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with revisions of HPV application, after review by Gavi, if necessary">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Responded to pre-review comments, and additional comments expected from GAVI after IRC review.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV application submitted to Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&#xB7;&#xA0;&#xA0; Technical support for outline and development of HPV application">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Workshop was held April 13-15 to finalize the application documents. HPV Application was submitted to Gavi by the country. Gavi IRC will review the application in July if the country submits the signature page by the end of June.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;amelioration de la disponibilite et la gestion des vaccins ainsi que la gestion de la chaine de froid dans les districts des regions de Kayes, Sikasso, Mopti et Segou">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Au cours de ce premier semestre, les revues des donnees ont ete appuyees non seulement au niveau des districts prioritaires mais aussi das les autres districts. Un exercice de triangulation a realise dans le district de Kati dans deux aires de sante a donne des resultats suivants: Lors de la visite de terrain &#xE0; Kita r&#xE9;alis&#xE9;e en f&#xE9;vrier 2021, la situation suivante a &#xE9;t&#xE9; analys&#xE9;e :
Aire de sante de Goro : stock de penta d&#xE9;but : 50doses ; Stock re&#xE7;u 150 doses soit 200 doses disponibles avec 180 enfants vaccines au penta
Aire de Sante de Sirakore en janvier 2021 : l?analyse faite en comparant les enfants vaccin&#xE9;s &#xE0; la couverture sur le DHIS2 : pour une cible de 62 enfants, 44 enfants vaccines mais la couverture retrouv&#xE9;e dans le DHIS2 donne 158% avec les m&#xEA;mes couvertures de 158% en penta 3, VAR1 
Cette situation a &#xE9;t&#xE9; restitu&#xE9;e a l?&#xE9;quipe cadre, car malgre les plus de 100% en VAR, l?aire de sante &#xE9;tait en &#xE9;pid&#xE9;mie de rougeole</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">[Y/N] Evidence-based supply chain modelling exercise completed, presenting alternatives, and analyzing VfM, sustainability, and zero-dose contributions.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Am&#xE9;liorer la gestion des vaccins et intrants du niveau central jusqu&apos;aux districts, par le renforcement de capacite des gestionnaires PEV notamment des districts prioritaires; 
Ameliorer la gestion des equipements de la cahine de froid par une mise &#xE0; jour periodique de l&apos;inventaire, du plan de rehabilitation et un suivi mensuel des temperatures; 
Mettre en place un suivi r&#xE9;gulier de la performance des equipements de froid, notamment en conduisant une cartographie de temperature de toutes les chambres froides quand necessaire et un suivi mensuel des temperatures &#xE0; distance">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Au terme du processus de selection du partenaire devant conduire l&apos;etude sur le systeme de chaine d&apos;approvisionnment, l&apos;ONG JSI a ete identifiee. Un premier atelier atelier D?ANALYSE ET DE CONCEPTION DE LA CHAINE D?APPROVISIONNEMENT EN VACCIN ET CONSOMMABLES AU MALI qui pour objectif global de relever les attentes des intervenants et des d&#xE9;cideurs en mati&#xE8;re de la chaine d&apos;approvisionnement, la collaboration dans le travail de la cha&#xEE;ne d&apos;approvisionnement et les r&#xF4;les et responsabilit&#xE9;s potentiels ; et aussi de fournir aux participants une compr&#xE9;hension claire des principes sur la conception d?un syst&#xE8;me de cha&#xEE;ne d?approvisionnement, les activit&#xE9;s r&#xE9;centes et/ou planifi&#xE9;es pour l?am&#xE9;lioration de la cha&#xEE;ne d?approvisionnement. Le processus est actuellement a l&apos;etape de la collecte des donnees sur terrain qui aideront a faire la modelisation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">% of target sites (provinces/districts) that have updated CCE management documents like CCE inventory, Operational Deployment Plan (ODP) or Cold Chain Expansion and Rehabilitation Plan, CCE maintenance strategy etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Am&#xE9;liorer la gestion des vaccins et intrants du niveau central jusqu&apos;aux districts, par le renforcement de capacite des gestionnaires PEV notamment des districts prioritaires; 
Ameliorer la gestion des equipements de la cahine de froid par une mise &#xE0; jour periodique de l&apos;inventaire, du plan de rehabilitation et un suivi mensuel des temperatures; 
Mettre en place un suivi r&#xE9;gulier de la performance des equipements de froid, notamment en conduisant une cartographie de temperature de toutes les chambres froides quand necessaire et un suivi mensuel des temperatures &#xE0; distance">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Avec la preparation et l&apos;organisation de la campagne contre COVID-19, 100% des districts ont actualise , grace a l&apos;Outil &quot;Inventory tools&quot; leurs equipements de la chaine de froid. Pour ameliorer la gestion des vaccins, un renforcement des capacites des prestataires des districts en SMT etait prevu; cette formation a ete reportee en debut du mois de decembre a cause de chevauchement des activites notamment la campagne contre COVID et la conduite des ateliers notamment les Plans Integres de Communication . Le Mali, avec l&apos;appui de l&quot;UNICEF et de JSI, vient , a l&apos;issue d&apos;une etude sur le systeme de chaine d&apos;approvisionnent conduite par l&apos;ONG JSI, d&apos;identifier un modele de chaine d&apos;approvisionnement qui permet, non seulement d&apos;ameliorer la disposnibilite des vaccins et en meme temps assurer la supervision a chaque niveau lors de la distribution des intrants. Il a ete convenu que ce modele v a etre teste dans les regions de Sikasso et de Gao. Une feuille de route a ete elabore a l&apos;issue de cet atelier. Avec l&apos;appui du gouvernement japnais, les equipes des districts vont etre renforcees en maintenance de ECF pour ameliorer la gestion generle de la chaine de froid au niveau peripherique</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessement of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;amelioration de la disponibilite et la gestion des vaccins ainsi que la gestion de la chaine de froid dans les districts des regions de Kayes, Sikasso, Mopti et Segou">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Sur le plan logistique, l&apos;amelioration de la gestion des vaccins s&apos;est faite atravers l&apos;organisation des inventaires mensuels des vaccins, le suivi de la maintenance des equipements de chaine de froid (a Kayes, 34 refrigerateurs ont ete repares et sont fonctionnels) et le suivi des temperatures. La formation des equipes des districts en SMT pourrait etre un plus dans l&apos;amelioration de la gestion des vaccins et ECF</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">* 100% des districts prioritaires (23) soumettent le SMT mensuel des vaccins au niveau central;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; * le volume de stockage de vaccins disponible au niveau central, au niveau des regions et au niveau districts est connu</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="- Renforcer le groupe de travail national sur la logistique, y compris le suivi de la mise en ?uvre des plans d?am&#xE9;lioration de la gestion de la cha&#xEE;ne d?approvisionnement. - Apporter un appui technique a la realisation de l&apos;etude sur l&apos;optimisation de la chaine d&apos;approvisionnement en vaccins. - Mener des &#xE9;valuations p&#xE9;riodiques de la gestion effective des vaccins (GEV).Assurer une mise a jour periodique des plans de rehabilitation et de maintenance des equipements de chaine de froid. - Mettre a jour l&apos;inventaire des equipements de chaine de froid. - Renforcer les capacites des acteurs sur la maintenance preventive et corrective des equipements de chaine de froid. - Assurer un suivi adequat&#xA0; du fonctionnement des dispositifs de controle de la temperature et l&apos;exploitation des resultats( cartographie des chambres froides, suivi de la temperature a distance, enregistrement continu, feuille de temperature). - Examiner mensuellement les donnees de gestion des stocks de vaccins (SMT)et proposer des mesures correctrices. Mettre en place une base de donnees de suivi de la temperature de chaine de froid. Assurer le suivi mensuel des niveaux de stocks de vaccinsau niveau national, regional et district. - Coordonner les inventaires des vaccins 2x/an au niveau national et 4x/an au niveau regional et district.">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 23 Districts Sanitaires soumettent le SMT mensuel des vaccins au niveau Central. L&apos;inventaire des equipements de Chaine de Froid a ete actualise en mars 2021 dans le cadre de l&apos;introduction du vaccin contre la Covid. Ce qui a permis de beneficier de 40 refrigerateurs solaires et electriques, 4,000 porte vaccins et 400 fridge tag. Les fonds ont ete deja vires a SD Copenhague a hauteur de 530,00 us et nous sommes dans l&apos;attente de la livraison de ces equipements. La capacite de stockage au niveau national, regional et district est connu et elle est suffisante.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AEDES : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monthly monitoring of the level of implementation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Technical support for planning, supervision and monitoring and evaluation activities of the immunization section
?	Close technical support to the Head of the Immunization Section
?	Close support to the CCIA technical secretariat">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Toutes les activit&#xE9;s orient&#xE9;es sur la vaccination COVID 19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; the EPI annual work plan 2021 is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Technical support for planning, supervision and monitoring and evaluation activities of the immunization section
?	Close technical support to the Head of the Immunization Section
?	Close support to the CCIA technical secretariat">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Toutes les activit&#xE9;s orient&#xE9;es sur la vaccination COVID 19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 2 coordination meetings held,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Technical support for planning, supervision and monitoring and evaluation activities of the immunization section
?	Close technical support to the Head of the Immunization Section
?	Close support to the CCIA technical secretariat">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 50% of monitoring and evaluation meetings,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Technical support for planning, supervision and monitoring and evaluation activities of the immunization section
?	Close technical support to the Head of the Immunization Section
?	Close support to the CCIA technical secretariat">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le protocole d&apos;enqu&#xEA;te est finalis&#xE9; et le consultant identifi&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a la pr&#xE9;paration de la revue externe du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">En raison de la campagne contre la COVID-19, le minist&#xE8;re de la sant&#xE9; a repouss&#xE9; cette activit&#xE9;, nous allons apporter l&apos;assistance technique d&#xE9;s qu&apos;il exprimera le besoin.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assurer le suivi et la r&#xE9;gularit&#xE9; des quatres r&#xE9;unions du groupe qualit&#xE9; des donn&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien &#xE0; l&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;appui continue dans le renforcement de la qualit&#xE9; des donn&#xE9;es.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assurer le suivi et la r&#xE9;gularit&#xE9; des deux r&#xE9;unions du groupe qualit&#xE9; des donn&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien &#xE0; l&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;appui est apport&#xE9; au groupe qualit&#xE9; des donn&#xE9;es &#xE0; travers les analyses et r&#xE9;unions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les appuis techniques sont identifi&#xE9;s et deployes au Mali</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutien a la pr&#xE9;paration de la revue externe du PEV">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Un comit&#xE9; technique a &#xE9;t&#xE9; mis en place avec &#xE9;laboration des termes de r&#xE9;f&#xE9;rence en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport d&apos;&#xE9;valuation est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation l?introduction 2eme dose de VAR">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">&#xC9;valuation effectu&#xE9;e et rapport disponible</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation l?introduction 2eme dose de VAR">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">&#xC9;valuation effectu&#xE9;e et rapport disponible</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AEDES : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress report on the development of the FPP including the situation analysis, identification of key activities for new grants, particularly, the extension of the vaccine equity strategy and the achievement of zero-dose children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the costed planning of GAVI&apos;s complete ?portfolio? (FPP) for the next five years">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">D&#xE9;but de l?activit&#xE9; en 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on ICC meeting  held</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Close support to the ICC technical secretariat for the preparation and organization of ICC meetings, as well as for monitoring resolutions and providing training for its members">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Formation des membres du CCIA en ligne pr&#xE9;vue en 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">? Joint evaluation,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Technical support for planning, supervision and monitoring and evaluation activities of the immunization section ? Close technical support to the Head of the Immunization Section ? Close support to the CCIA technical secretariat">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Rapport pr&#xE9;par&#xE9; en &#xE9;troite collaboration avec les autres partenaires</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Proposal for a roadmap for the implementation of the digitization of registers submitted [to Gavi]
Regional meetings to exchange and share experiences are held</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducting a feasibility study to determine a realistic roadmap for expanding digital registries">
      <location ref="ML"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Report&#xE9; pour 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3 supported monitoring and evaluation meetings
Update of work plans -Support for the production of strategic documents (EPI external review, PPAC, RSS Plan)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Local technical support to the Head of the Immunization Section for planning activities (programming, mechanisms for monitoring actions, in particular those financed by GAVI, reporting, etc.), integrated supportive supervision (Revision of supervision guides and tools) and monitoring and evaluation of the immunization section (monitoring and evaluation meetings) and the organization of campaigns">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">see following milestones</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of the anti-COVID campaign
- Support the continued expansion of the campaign in other regions of the country
- Support the periodic review of the implementation of the campaign
- Analysis of reported data to guide decisions regarding the implementation of the campaign
- Support the final evaluation of the campaign
- Support campaign coordination meetings
- Participate in meetings of the campaign staff
Document and capitalize on the implementation of the campaign">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">WG meetings are held monthly with reports
Orientation report of the SNIS strategic plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the improvement of data quality; Support for periodic reviews of EPI data;
Support for the preparation and organization of Data Quality WG meetings (work plan, activities related to the data quality improvement chain, ...)
Support for the development of the next SNIS strategic plan, including a focus on improving data quality">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on start-up workshop carried out

Regional meetings to exchange and share experiences are held</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the documentation / capitalization of strategies for improving vaccine equity (ACE; urban strategy)">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AEDES : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Synthesis report highlighting the effects and practices of the two strategies</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for documentation / capitalization of strategies to improve vaccine equity (ACE; urban strategy):">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins quatre r&#xE9;unions du GTCV quatre r&#xE9;unions du Comit&#xE9; des experts MAPI, avec compte-rendu</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le fonctionnement des organes de coordination et de gouvernance notamment  le GTCV, le Comit&#xE9; des experts MAPI">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le fonctionnement des organes de coordination et de gouvernance notamment  le GTCV, le Comit&#xE9; des experts MAPI">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;exp&#xE9;rience est partag&#xE9;e avec d&apos;autres districts et r&#xE9;gions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du leadership et de la gouvernance des FENASCOM de Kayes avec focus sur les ASACO des districts prioritaires en collaboration avec la FENASCOM">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le renforcement du leadership et de la gouvernance des FENASCOM de Kayes avec focus sur les ASACO des districts prioritaires en collaboration avec la FENASCOM">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Performance management system in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui cons&#xE9;quent au niveau op&#xE9;rationnel
* Renforcer l?excellence op&#xE9;rationnelle aupr&#xE8;s du personnel du PEV, &#xE0; travers un accompagnement ad-hoc.
(facilitation de r&#xE9;unions, formalisation de documents de travail, assistances diverses dans les domaines du LMC des MP).">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Immunization campaign dashboards developed by MP1 and EPI. Praised by W.H.O. 
Adding balance scorecards for Covax campaign monitoring.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le management du PEV en optimisant sa coordination interne et au niveau central Assister la coordination de l?assistance technique au niveau du PEV, * dans la mise en place d?une structure de pilotage de programmes (PMO), * dans la mise en ?uvre des am&#xE9;liorations de process suivant les recommandations de la premi&#xE8;re phase de l?appui LMC par Dalberg * dans l?application du cadre de redevabilit&#xE9; au niveau central">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Immunization campaign dashboards developed by MP1 and EPI. Praised by W.H.O. 
Adding balance scorecards for Covax campaign monitoring.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le management du PEV en optimisant sa coordination interne et au niveau central
Assister la coordination de l?assistance technique au niveau du PEV, 
* dans la mise en place d?une structure de pilotage de programmes (PMO), 
* dans la mise en ?uvre des am&#xE9;liorations de process suivant les recommandations de la premi&#xE8;re phase de l?appui LMC par Dalberg 
* dans l?application du cadre de redevabilit&#xE9; au niveau central">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Immunization campaign dashboards developed by MP1 and EPI. Praised by W.H.O. 
Adding balance scorecards for Covax campaign monitoring.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le management du PEV en optimisant sa coordination interne et au niveau central
Assister la coordination de l?assistance technique au niveau du PEV, 
* dans la mise en place d?une structure de pilotage de programmes (PMO), 
* dans la mise en ?uvre des am&#xE9;liorations de process suivant les recommandations de la premi&#xE8;re phase de l?appui LMC par Dalberg 
* dans l?application du cadre de redevabilit&#xE9; au niveau central">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual workplan and budgets include interventions to reach zero dose children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="D&#xE9;velopper la mise en ?uvre d?une strat&#xE9;gie pour renforcer l?action du PEV dans les zones de conflits
* Identifier acteurs en pr&#xE9;sence, contributions au PEV, disparit&#xE9;s dans la demande et &#xE9;carts dans les services
* Faciliter mobilisation coordonn&#xE9;e et suivi des activit&#xE9;s de l?ensemble des parties prenantes
* G&#xE9;n&#xE9;rer partenariats avec acteurs nationaux et internationaux en zones de conflits (UNOPS, Croix Rouge, Croissant Rouge?) et autres organisations &#xE9;ligibles">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Led by W.H.O, MP1 assisted the reshape of zero dose children identification model. Priority district idedntified and ranked by importance. Ressultss validated with EPI, UNICEF and AEDES.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutenir la coordination des activit&#xE9;s du PEV au niveau d&#xE9;centralis&#xE9; * Veiller &#xE0; la mise en place effective des micro-plans et leur suivi au niveau d&#xE9;centralis&#xE9; * Veiller au d&#xE9;veloppement d?un process partag&#xE9; pour la remont&#xE9;e des dysfonctionnements * Faire du cadre de redevabilit&#xE9; un outil fonctionnel et suivi, au niveau central et d&#xE9;centralis&#xE9; * Conduire des ateliers de conduites du changement pour accro&#xEE;tre l?appropriation des nouveaux outils et pratiques">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Led by W.H.O, MP1 assisted the reshape of zero dose children identification model. Priority district idedntified and ranked by importance. Ressultss validated with EPI, UNICEF and AEDES.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutenir la coordination des activit&#xE9;s du PEV au niveau d&#xE9;centralis&#xE9;
* Veiller &#xE0; la mise en place effective des micro-plans et leur suivi au niveau d&#xE9;centralis&#xE9;
* Veiller au d&#xE9;veloppement d?un process partag&#xE9; pour la remont&#xE9;e des dysfonctionnements
* Faire du cadre de redevabilit&#xE9; un outil fonctionnel et suivi, au niveau central et d&#xE9;centralis&#xE9;
* Conduire des ateliers de conduites du changement pour accro&#xEE;tre l?appropriation des nouveaux outils et pratiques">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Led by W.H.O, MP1 assisted the reshape of zero dose children identification model. Priority district idedntified and ranked by importance. Ressultss validated with EPI, UNICEF and AEDES.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutenir la coordination des activit&#xE9;s du PEV au niveau d&#xE9;centralis&#xE9;
* Veiller &#xE0; la mise en place effective des micro-plans et leur suivi au niveau d&#xE9;centralis&#xE9;
* Veiller au d&#xE9;veloppement d?un process partag&#xE9; pour la remont&#xE9;e des dysfonctionnements
* Faire du cadre de redevabilit&#xE9; un outil fonctionnel et suivi, au niveau central et d&#xE9;centralis&#xE9;
* Conduire des ateliers de conduites du changement pour accro&#xEE;tre l?appropriation des nouveaux outils et pratiques">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI organogram revised to reflect core functions such as policy and planning, surveillance, vaccine stock management, M&amp;E, fund management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le leadership du PEV en l?appuyant dans sa coordination avec les institutions et partenaires * Accompagner le renforcement institutionnel du PEV au sein du Minist&#xE8;re de la Sant&#xE9; * Assister le PEV dans sa coordination avec des entit&#xE9;s publiques et priv&#xE9;es partenaires * Faciliter le d&#xE9;veloppement de nouveaux partenariats l&#xE0; o&#xF9; le besoin sera identifi&#xE9; * Seconder AEDES, dans la redynamisation du CCIA">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">New organizational structure reviewed by MP1, EPI, and MoH. Surveillance, vaccine management positions added. Policy and planning added to EPI coordination team responsibilities. Implementation of new structure pending validation from the Institutional Development Committee (cross government authority). Target approval December 2021 or Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le leadership du PEV en l?appuyant dans sa coordination avec les institutions et partenaires
* Accompagner le renforcement institutionnel du PEV au sein du Minist&#xE8;re de la Sant&#xE9;
* Assister le PEV dans sa coordination avec des entit&#xE9;s publiques et priv&#xE9;es partenaires
* Faciliter le d&#xE9;veloppement de nouveaux partenariats l&#xE0; o&#xF9; le besoin sera identifi&#xE9;
* Seconder AEDES, dans la redynamisation du CCIA">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">New organizational structure reviewed by MP1, EPI, and MoH. Surveillance, vaccine management positions added. Policy and planning added to EPI coordination team responsibilities. Implementation of new structure pending validation from the Institutional Development Committee (cross government authority). Target approval December 2021 or Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer le leadership du PEV en l?appuyant dans sa coordination avec les institutions et partenaires
* Accompagner le renforcement institutionnel du PEV au sein du Minist&#xE8;re de la Sant&#xE9;
* Assister le PEV dans sa coordination avec des entit&#xE9;s publiques et priv&#xE9;es partenaires
* Faciliter le d&#xE9;veloppement de nouveaux partenariats l&#xE0; o&#xF9; le besoin sera identifi&#xE9;
* Seconder AEDES, dans la redynamisation du CCIA">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
6. LMIS digital package installed
7. Birth notifiation digital package installed
8. Scorecard app installed
9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Delays in activities due to challenges in getting funding for in-country workshop : Waiting for the signing of MoU between MoH, Unicef and Gavi</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry digital package configured and installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="ML"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Delays in activities due to challenges in getting funding for in-country workshop : Waiting for the signing of MoU between MoH, Unicef and Gavi</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">System installed and configured. Now waiting for funding from WHO to coonduct ToT</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 6. LMIS digital package installed 7. Birth notifiation digital package installed 8. Scorecard app installed 9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry piloted in one district.
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;-Develop a performance reward framework for the EPI staff, the regional level and the district level that achieve their goals 
Develop a concept note on the performance framework to be discussed with partners for funding&quot;
-Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners &quot;
&quot;
- Develop job descriptions for each EPI staff to be validated and disseminated by the EPI lead
- Desing HR tools to support a transparent recruiting process that integrates the Alliance Members
- Develop a capacity building plan for the EPI staff&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Instill a results and performance-driven culture through the establishment of accountability framework">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">#NAME?</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Instill a results and performance-driven culture through the establishment of accountability framework">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">- Completed process analysis and organizational design analysis based on operational performance, with the feedbacks of EPI, WHO, UNICEF, AEDES and Planning division of MoH. A final review have been conducted in workshops with EPI and partner organizations. 
- Completed main job descriptions based on official position details created by MoH and best-practices. A final review have been conducted in workshops with EPI unit leaders.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop a final report on the next steps to fully implement the recommendations from the organizational assessment and ensure its sustainability
-Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners &quot;
&quot;
- Develop job descriptions for each EPI staff to be validated and disseminated by the EPI lead
- Desing HR tools to support a transparent recruiting process that integrates the Alliance Members
- Develop a capacity building plan for the EPI staff&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing an optimized organizational chart">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">- Completed process analysis and organizational design analysis based on operational performance, with the feedbacks of EPI, WHO, UNICEF, AEDES and Planning division of MoH. A final review have been conducted in workshops with EPI and partner organizations. 
- Completed main job descriptions based on official position details created by MoH and best-practices. A final review have been conducted in workshops with EPI unit leaders.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing an optimized organizational chart">
      <location ref="ML"></location>
     </target>
     <actual value="Completed">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">- Completed process analysis and organizational design analysis based on operational performance, with the feedbacks of EPI, WHO, UNICEF, AEDES and Planning division of MoH. A final review have been conducted in workshops with EPI and partner organizations. 
- Completed main job descriptions based on official position details created by MoH and best-practices. A final review have been conducted in workshops with EPI unit leaders.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- Implement/revitalize coordination mechanisms between the central and the subnational levels - Provide tools for the preparation of coordination sessions levels to improve the decision-making process at the regional level and ensure the implementation of decisions - Ensure discussions at the ICC level will cover the strategic dysfunctions at the subnational level Develop a concept note on the performance framework to be discussed with partners for funding&quot; -Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners &quot; &quot; - Develop job descriptions for each EPI staff to be validated and disseminated by the EPI lead - Desing HR tools to support a transparent recruiting process that integrates the Alliance Members - Develop a capacity building plan for the EPI staff&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve internal and external coordination through adequate organisatonal, and reporting tools">
      <location ref="ML"></location>
     </target>
     <actual value="On Track">
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">- MP1 Advocated for subnational level inclusion. Since then meeting with subnational level have been held biweekly.
- MP1 Assisted EPI in organizing, facilitating and following up on ICC. EPI is now fully autonomous on this topic and tackles strategic matters during each ICC meeting
- Work on performance framework on hold due to strong focus on managing the sevral introductions of COVID-19 vaccines in the campaign (AZN, Sinovac, J&amp;J, Pfizer...) (MP1)
- Mapping of governance and coordination bodies in process with MP3
- Job descriptions completed. Shared with EPI lead. EPI. lead still has to disseminate the job descriptions (MP1)
- HR recruitment tool completed (MP1)
- Capacity building plan for EPI empowerment completed (MP1)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;- Implement/revitalize coordination mechanisms between the central and the subnational levels 
- Provide tools for the preparation of coordination sessions levels to improve the decision-making process at the regional level and ensure the implementation of decisions 
- Ensure discussions at the ICC level will cover the strategic dysfunctions at the subnational level&quot;
Develop a concept note on the performance framework to be discussed with partners for funding&quot;
-Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners &quot;
&quot;
- Develop job descriptions for each EPI staff to be validated and disseminated by the EPI lead
- Desing HR tools to support a transparent recruiting process that integrates the Alliance Members
- Develop a capacity building plan for the EPI staff&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve internal and external coordination  through adequate organisatonal, and reporting tools">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Part of the work have been done but the work is in progress at certain level such as:
-Ensure discussions at the ICC level will cover the strategic dysfunctions at the subnational level&quot; Develop a concept note on the performance framework to be discussed with partners for funding&quot; -Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve internal and external coordination  through adequate organisatonal, and reporting tools">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
      <comment>
       <narrative xml:lang="EN">Part of the work have been done but the work is in progress at certain level such as:
-Ensure discussions at the ICC level will cover the strategic dysfunctions at the subnational level&quot; Develop a concept note on the performance framework to be discussed with partners for funding&quot; -Map governance and coordination bodies at the central and decentralized levels and develop a workplan for revitalization that will be shared with all the partners.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-Finalize the new organizational chart integrating the various comments received on the report - Develop job descriptions for each EPI staff to be validated and disseminated by the EPI lead - Desing HR tools to support a transparent recruiting process that integrates the Alliance Members - Develop a capacity building plan for the EPI staff</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing an optimized organizational chart">
      <location ref="ML"></location>
     </target>
     <actual>
      <location ref="ML"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
